In addition, Nick Johnston will join the Firm’s London office as a Managing Director in the Advisory Group, also focusing on healthcare sector clients. McAuliffe and Johnston join a growing team of advisory professionals covering the healthcare sector globally.
McAuliffe has over 15 years of investment banking experience. He was most recently a Managing Director in JPMorgan’s Healthcare Investment Banking Group, where he advised a broad range of clients in the medical device and diagnostics sector. Prior to this, he was a member of JPMorgan’s Equity Private Placements Group, where he led the healthcare practice.
Johnston also has significant healthcare related experience. He previously served as an Executive Director in JPMorgan’s investment banking group, where he focused on healthcare clients across multiple sectors. He has also worked directly for healthcare companies.
Peter Weinberg, a Founding Partner of Perella Weinberg Partners said, 'The healthcare sector is an important area for the Firm and we are pleased to broaden our global advisory capabilities with high-caliber talent. The addition of Philippe and Nick represents a synergistic expansion of our existing healthcare subsector coverage within the U.S. and Europe. They add a unique perspective to the group, and we are confident that their deep industry knowledge and strong client relationships will complement the team as we continue to grow our advisory franchise'.
Philippe McAuliffe said, 'Perella Weinberg Partners has developed a well-respected independent advisory business and I am pleased to be joining the healthcare team as they continue to build out the franchise. I look forward to working with them and the other advisory professionals to help our healthcare clients meet their strategic needs in this transforming environment'.
Perella Weinberg Partners has been actively advising healthcare clients globally. Some of the Firm’s recent assignments include advising:
Luminex Corporation in connection with its acquisition of GenturaDx;
The Linde Group in connection with its $4.6 billion acquisition of Lincare Holdings, Inc.;
Hologic, Inc. in connection with its $3.7 billion acquisition of Gen-Probe Incorporated;
Rhön-Klinikum AG in connection with the voluntary public takeover offer by Fresenius SE & Co. KGaA valued at €3.9 billion; and
Caliper Life Sciences, Inc. in connection with its sale to PerkinElmer, Inc. for $600 million.
Philippe McAuliffe -
Philippe McAuliffe is a Partner at Perella Weinberg Partners. Prior to joining the Firm, McAuliffe was a Managing Director at JPMorgan, where he advised a broad range of clients in the medical device and diagnostics sector. He previously served in JPMorgan’s Equity Private Placements Group where he managed the healthcare practice and started his career in the Healthcare Investment Banking Group at Hambrecht & Quist, which was acquired by JPMorgan Chase in 1999.
McAuliffe received a B.S.E. in Civil Engineering and a Certificate in Engineering Management Systems from Princeton University and a M.B.A. in Finance from Columbia Business School.
Nick Johnston will be a Managing Director at Perella Weinberg Partners. Most recently, Johnston was an Executive Director in the Healthcare Investment Banking Division at JPMorgan, where he focused on clients in the pharmaceutical, specialty pharmaceutical and medical device industries.
Previously, he was Chief Operating Officer of the operating subsidiaries of Microsulis Limited, a multi-million dollar medical technology company, and he earlier co-founded a development-stage pharmaceutical company, where as Vice President of Business he led all operational functions, corporate strategy implementations and fund-raising initiatives. Johnston began his career with JPMorgan in its New York and London offices.
Johnston received a Bachelor of Arts in Political Science and English, with honors, from the University of North Carolina at Chapel Hill.